Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several positive trials, a recent study has confirmed the efficacy of a biotherapy, ...

The AHA has published a scientific statement regarding disparities in current pulmonary embolism management and outcomes.